ROTH

PharmaRoth Labs, Inc. ROTH

ROTH
PharmaRoth Labs, Inc. DECN
Decision Diagnostics Corp. PRMD
Primemd Inc. SXHHF
Sonomax Technologies Inc WIBFF
West Island Brands Inc. ITMC
Itoco Inc. LGND
Ligand Pharmaceuticals Incorporated MEDD
Medical Imaging Corp. AXMP
AXM Pharma, Inc. AMBS
Amarantus BioScience Holdings, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ROTH DECN PRMD SXHHF WIBFF ITMC LGND MEDD AXMP AMBS
6M 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 100.00 % 71.58 % 0.00 % 49.25 % -96.67 %
YTD 0.00 % 9 900.00 % 0.00 % 0.00 % 0.00 % -85.71 % 81.96 % 0.00 % 9 900.00 % -90.00 %
1Y 0.00 % 9 900.00 % 0.00 % 0.00 % 0.00 % -85.71 % 73.36 % 0.00 % 9 900.00 % -90.00 %
3Y 1 900.00 % 0.00 % -99.78 % 9 900.00 % -95.78 % -99.54 % 193.05 % -50.00 % 9 900.00 % -99.38 %
5Y -80.00 % -99.66 % -99.00 % 9 900.00 % -99.39 % -99.68 % 86.69 % -98.57 % -50.00 % -99.86 %
10Y -97.78 % -99.88 % -95.71 % 9 900.00 % -99.39 % -99.95 % 83.72 % -99.78 % -99.49 % -100.00 %
From the beginning -99.88 % -100.00 % -99.90 % 9 900.00 % -99.88 % -100.00 % 330.26 % -99.98 % -99.49 % 13 964.70 %

Dividend

Ligand Pharmaceuticals Incorporated